
Regeneron invest $800 million into New York facilities
pharmafile | August 15, 2019 | News story | Medical Communications | East Greenbush, New York, Regeneron, pharma
Regeneron is investing $800 million into its New York production facilities.
The firm is planning to build a four story Science Building containing labs and offices, and a six story car park with capacity for 1,020 cars, in the town of East Greenbush in New York State.
The new facility will bring 1,050 new workers to the town making it will be one of the region’s biggest employers. There will be around 4,000 and 5,000 Regeneron employees in East Greenbush overall.
According to documents filed by Jacobs, the engineering firm handling the project, “construction for the site development and two structures will take approximately 30 to 36 months.”
Louis Goss
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

Regeneron announces presentations of new data on Eylea HD for retinal disease
Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data …






